berberine has been researched along with Mucocutaneous Lymph Node Syndrome in 1 studies
Mucocutaneous Lymph Node Syndrome: An acute, febrile, mucocutaneous condition accompanied by swelling of cervical lymph nodes in infants and young children. The principal symptoms are fever, congestion of the ocular conjunctivae, reddening of the lips and oral cavity, protuberance of tongue papillae, and edema or erythema of the extremities.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Xu, M | 1 |
| Qi, Q | 1 |
| Men, L | 1 |
| Wang, S | 2 |
| Li, M | 1 |
| Xiao, M | 1 |
| Chen, X | 1 |
| Wang, G | 1 |
| Jia, H | 1 |
| Liu, C | 1 |
1 other study available for berberine and Mucocutaneous Lymph Node Syndrome
| Article | Year |
|---|---|
Berberine protects Kawasaki disease-induced human coronary artery endothelial cells dysfunction by inhibiting of oxidative and endoplasmic reticulum stress.
Topics: Antioxidants; Apoptosis; Berberine; Case-Control Studies; Cells, Cultured; Coronary Artery Disease; | 2020 |